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ABSTRACT 
Hernandez Buquer, Selene. M.S., Purdue University, May 2014 Characterization of Fatty 
Acid Elongase Condensing Enzyme by Site-Directed Mutagenesis and Biochemical 
Analysis. Major Professor: Brenda Blacklock. 
 
 
 
Fatty acid elongation is the extension of de novo synthesized fatty acids through a series 
of four reactions analogous to those of fatty acid synthase.  ELOs catalyze the first 
reaction in the elongation pathway through the condensation of an acyl group with a two-
carbon unit derived from malonyl-CoA.  This study uses the condensing enzyme, EloA, 
from the cellular slime mold, Dictyostelium discoideum as a model for the family of 
ELOs.  EloA has substrate specificity for monounsaturated and saturated C16 fatty acids 
and catalyzes the elongation of 16:1△9 to 18:1△11.  Site-directed mutagenesis was used to 
change residues highly conserved among the ELO family to examine their potential role 
in the condensation reaction.  Mutant EloAs were expressed in yeast and fatty acid 
methyl esters prepared from total cellular lipids were analyzed by gas 
chromatography/mass spectrometry.  Sixteen out of twenty mutants had a decrease in 
18:1Δ11 production when compared to the wild-type EloA with little to no activity 
observed in ten mutants, four mutants had within 20% of wild-type activity, and six 
mutants had 10-60% of wild-type activity.  Immunoblot studies using anti-EloA serum 
were used to determine if the differences in elongation activity were related to changes in 
protein expression for each mutant.  Analysis of immunoblots indicated that those 
mutants with little to no activity, with the exception of T130A and Q203A, had  
x 
 
x 
comparable protein expression to the wild-type. Further research included the 
solubilization of the His6-ELoA fusion protein and preliminary work toward the isolation 
of the tagged protein and the use of a radiolabeled condensation assay to determine the 
activity of the eluted protein.  Preliminary results indicated that the protein was 
solubilized but the eluted protein showed no activity when examined by a condensation 
assay.  The work presented here contributes to a better understanding of the role of 
certain amino acid residues in the activity of EloA and serves as a stepping-stone for 
future EloA isolation work.  
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CHAPTER 1. INTRODUCTION 
1.1 Lipids and Very Long-Chain Fatty Acids 
Lipids are structurally diverse and serve many biological functions such as the 
formation of the cellular membrane, regulation of the fluidity of the lipid bilayer, signal 
transduction and energy storage.  Lipids are classified as fatty acids, sterols, oils, and 
sphingolipids among others (1).  The structural diversity of lipids allows for different 
roles in biochemical processes.  For example, the myelin sheath that surrounds the axons 
in nerve cells are rich in sphingomyelin (2).  Additionally, lipids affect protein structure 
and activity thus affecting cellular function; protein function is affected by protein-lipid 
interactions, which depend on factors such as chain length, degree of unsaturation, and 
backbone structure among others (1).  Overall, the chemical and physical properties of 
lipids allow them to be involved at many levels of cellular function. 
 
Many lipids are classified as long-chain fatty acids depending on their chain 
lengths.  Very long-chain fatty acids (VLCFA) have chain lengths of C18 and greater and 
play pivotal intracellular roles such as maintaining cellular structure and regulation and 
extracellular roles such as cuticular wax formation and energy storage.  The acyl chains 
of ceramides and more complex sphingolipids, the building blocks of membrane 
microdomains, are often VLCFAs (3).   
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VLCFAs are thought to stabilize curved membranes by being present in both leaflets of 
the lipid bilayer as well as aiding with the maintenance and function of the nuclear 
envelope (4).  Structurally, VLCFA are classified as saturated, monounsaturated or 
polyunsaturated very long chain fatty acids (5) (Figure 1.1) depending upon the extent of 
double bond formation.  
 
 
Figure 1.1.  A saturated (eicosanoic acid-20:0), monounsaturated (eicosenoic acid-
20:1Δ11), and polyunsaturated (arachidonic acid-20:4Δ5,8,11,14) VLCFA.  Nomenclature is 
in the Δx format, where the x indicates the location of the double bond counting from the 
carboxylic acid.  The number:number nomenclature represents the number of 
carbons:number of double bonds. 
 
 
Both land plants and animals exploit the hydrophobic nature of VLCFAs for protection 
against dehydration and the environment.  In plants, VLCFAs up to C32 are found as 
components of cuticular wax and suberin (6).  Additionally, some plant seed oils contain 
VLCFAs that are integrated into wax esters or triacyglyerols (7). 
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In Arabidopsis, more than fifty percent of VLCFAs are key components of wax synthesis 
that will produce aliphatic wax components to protect plant tissue from environmental 
factors and disease (6).  In mammals, VLCFAs longer than C30 are pivotal for the proper 
structure and function of the skin by creating a permeability barrier.  C22 fatty acids are 
an important component of lipids present in the retina and both arachidonic acid (AA, 
20:4Δ5,8,11,14) and eicosapentaenoic acid (EPA, 20:5Δ5,8,11,14,17) are precursors to 
eicosanoids which are involved in blood pressure regulation, cell signaling, blood clotting 
and inflammatory response (8, 9).  Furthermore, studies have shown that mutation of 
enzymes that synthesize VLCFAs can cause diseases in humans.  For example, a 
mutation of an elongase of very long chain fatty acids (ELOVL4), causes Stargardt 
disease-3, a disease leading to the accumulation of lipofuscin and central vision loss (8).  
In mammals, ELOVL4 is proposed to aid in the synthesis of docosahexaenoic acid which 
is present in the phospholipids found in the retina (8).  
 
Although VLCFAs participate in multiple biological processes, the mechanism 
that gives them their diverse chain lengths is not well understood.  VLCFAs are produced 
at the ER from de novo synthesized C16 and C18 fatty acids through the activity of a 
membrane-bound fatty acid elongase complex comprised of a condensing enzyme, two 
reductases, a dehydratase, and, as recently shown in plants, an immunophilin-like 
scaffolding protein (10).   
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1.1.2.  Fatty Acid Synthesis 
 Fatty acids are essential to all organisms and are long chain carboxylic acids.  
Common fatty acids are those with C16 or C18 chain lengths that can be saturated or 
unsaturated at multiple locations.  Fatty acid biosynthesis takes place in the cytosol and 
involves the condensation, catalyzed by fatty acid synthases, of C2 units derived from 
acetate to fatty acyl groups linked to the acyl-carrier protein (ACP) to produce essential 
fatty acids.  Fatty acid synthesis is catalyzed by either a type I system which involves a 
single polypeptide or a type II system that involves multiple separate polypeptides (11).  
Fatty acids in mammals takes place using a type I fatty acid synthase (FAS) while most 
bacterial and all plants use a type II system (11)  
 
The first reaction involves the addition of CO2 to acetyl-CoA catalyzed by acetyl-
CoA carboxylase to yield malonyl-CoA, a step that requires ATP.  The malonyl group is 
transferred to ACP as catalyzed by malonyl-CoA-ACP transacylase (MAT) to generate 
malonyl-ACP.  Simultaneously, the acetyl group from acetyl-CoA is transferred to ACP 
by acetyl-CoA-ACP transacylase (2).  The next step involves the condensation reaction, 
catalyzed by fatty acid synthase, of a C2 unit from malonyl-ACP with acetyl-ACP.  
Malonyl-CoA is decarboxylated resulting in the formation of a carbanion that attacks the 
acetyl-thioester bond in acetyl-ACP yielding 3-ketoacyl-ACP.  The subsequent reactions 
involve reduction of the 3-ketoacyl-ACP product, which involves NADPH as the electron 
donor and dehydration of the 3-hydroxyacyl-ACP product where the carbonyl group is 
converted into an alkyl group to yield the enoyl-ACP product, which is reduced (again 
requiring NADPH) to a product that is two carbons longer.  (Figure 1.2) (2).  
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Figure 1.2. Fatty acid biosynthesis overview. 
 
 
1.2 Fatty acid elongation and condensing enzymes 
In comparison to cytosolic fatty acid biosynthesis, fatty acid elongation takes 
place in the endoplasmic reticulum where a system of enzymes catalyze the condensation 
of a C2-unit from malonyl-CoA with an acyl-CoA primer (C16 or C18) to form an 
elongated 3-ketoacyl-CoA, the reduction of the carbonyl group to a hydroxyl group, 
followed by a dehydration to form a trans alkene.  The alkene is further reduced to yield a 
acyl-CoA product two carbons longer (12) (Figure 1.3).  The elongation of fatty acids 
requires malonyl-CoA, a product of the carboxylation of acetyl-CoA by acetyl-CoA 
carboxylase (Acc1) (13).  Once the malonyl-CoA, donor of two carbon units, is available 
the elongation process proceeds.  The first step of the fatty acid elongation process is the 
condensation, by a condensing enzyme (KCS/ELO) of acyl-CoA with the malony-CoA 
unit derived from Acc1 yielding a 3-ketoacyl-CoA product.  
fatty acyl-ACP (Cn)
malonyl-ACP HS-ACP + CO2
3-ketoacyl-ACP 3-hydroxyacyl-ACP
H2O
enoyl-ACP
NADPH + H+
NADP+
fatty acyl-ACP (Cn+2)
malonyl-CoA + HS-ACP
HS-CoA
NADPH + H+ NADP+
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Figure 1.3.  Fatty acid elongation pathway. 
 
 
Two families of fatty acid elongase condensing enzymes have been described 
previously: the ELOs and the 3-ketoacyl-CoA synthases (KCSs) (14-16).  Animals, fungi, 
and other higher-order eukaryotes accomplish fatty acid elongation with a distinct family 
of condensing enzymes, first described in Saccharomyces cerevisiae as ELOs, which 
have been modeled to span the membrane five to seven times (16-19).  Arabidopsis has 
predicted homologs to the ELOs (20).  In plants and protists, 3-ketoacyl-CoA synthases 
(KCSs) with sequence similarities to the canonical Fatty Acid Elongase 1 KCS (FAE1 
KCS) catalyze the initial step in fatty acid elongation and have apparent structural and 
catalytic similarities with the Type II fatty acid synthase  (FAS) condensing enzyme (10, 
21-25). 
 
Although ELOs and KCSs catalyze the condensation reaction with the same 
substrates (malonyl-CoA and acyl-CoA), they do not have topological or sequence 
similarities.  Classical KCSs catalyze fatty acid elongation through a Claisen-like 
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mechanism.  Sequence alignment and mutagenesis have demonstrated that FAE1 KCS 
possesses a catalytic triad identical to those found in fatty acid synthase and polyketide 
synthase condensing enzymes (Cys His His/Asn) (11, 26).  These enzymes catalyze the 
first step in elongation (26, 27) where the acyl-CoA substrate enters the active site first 
and, upon a nucleophilic substitution reaction, is covalently bound by the active site 
cysteine releasing the CoA moiety.  The malonyl-CoA substrate then enters the active site 
and, either in a step-wise or concerted fashion, is decarboxylated and the 
enolate/carbanion nucleophile formed attacks the carbonyl group of the acyl primer, 
generating the 3-ketoacyl CoA product via an enzyme-bound tetrahedral intermediate (11) 
(Figure 1.4). 
 
 
Figure 1.4.  Claisen-like condensation reaction mechanism illustrating the role of the 
catalytic triad (Cys/His/Asn) of a condensing enzyme during fatty acid elongation. 
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1.2.1   ELOs: condensing enzymes 
ELOs have substrate specificities that cover a wide range of fatty acid chain 
length and degrees of unsaturation and can be classified into phylogenetic clades based 
on their biochemically-characterized activity with saturated and mono- or 
polyunsaturated substrates (Figure 1.5) (28-30).   
 
 
Figure 1.5.  Phylogenetic tree of functionally characterized ELO family members.  EloA 
clusters with other ELOs with substrate specificities towards MUFA/SFA. 
 
In yeast, ELO2 and ELO3 are responsible for the production of the saturated C24 and C26 
acyl chains found in sphingolipids and a simultaneous disruption of the genes encoding 
these ELOs is synthetically lethal (13, 16, 18).  Additionally, ELO1 elongates medium 
and long-chain fatty acids.   
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Mutations in yeast ELOs demonstrate the importance of these enzymes in fatty acid 
elongation (13).  Mutations in ELO2 lead to defects in β-glucan synthase activity, glucans 
are polysaccharide polymers that are major components of the cell wall in S. cerevisiae 
(31).  In ELO3, mutations lead to decreased levels of ATPase by affecting the genes 
involved in the glucose-signaling pathway (32). 
 
Lower plants and microalgae produce polyunsaturated VLCFAs such as 
eicosapentaenoic acid and docosahexaenoic acid through the activities of ELOs and 
desaturases with distinct substrate specificities (33).  PSE1 (PUFA specific elongase) 
cDNA isolated from Physcomitrella patens, a moss, has homology with S. cerevisiae 
ELO genes.  The enzyme is involved in the elongation of Δ6-PUFAs (polyunsaturated 
fatty acids) found in P. patens and when disrupted production of all C20 PUFAs is lost 
(33). 
 
ELOs have been described in mammals where their functions are being elucidated 
currenlty.  ELO, ELOVL4, impacts the development of Stargardt disease (STGD3) the 
most common form of inherited macular dystrophy in which the macula (yellow spot 
near the retina of the eye) atrophies and a degeneration of retinal pigment epithelium is 
observed (8).  Three alleles have been identified for STGD3, each of which results in a 
truncated ELOVL4 protein that is missing the dilysine ER retention motif; the 
mislocalization of coexpressed mutant and wildtype ELOVL4 is thought to be the root of 
at least some of the phenotypic readout (34, 35).  Disruption of both copies of ELOVL4 
in mice results in a neonatal lethality where missing skin lipids results in the inability to 
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retain water (36).  Another mammalian ELO, ELOVL3 appears to have roles in the 
synthesis of triacyglycerols in the liver and their accumulation in adipose tissue (37, 38) 
while the very long chain polyunsaturated fatty acids produced by ELOVL2 are essential 
for spermatogenesis and male fertility (39).  ELOs are classified into two subfamilies 
based on sequence similarity, which correlates with substrate specificity.  ELOs show 
specificity toward monounsaturated and saturated fatty acids (MUFA/SFA) or toward 
polyunsaturated fatty acids (PUFA) (40) (Figure 1.5).   
 
Using reconstituted proteoliposomes (41), ELOs have been shown to catalyze the 
condensation of malonyl-CoA and acyl-CoA, however, little is known about the 
mechanism through which ELOs catalyze the condensation reaction in the elongation 
pathway.  Alignment of ELOs from different organisms showed highly conserved 
residues among the ELO family (Figure 1.6); however, there is no conserved Claisen-like 
condensing enzyme catalytic triad found in ELOs.   
 
Four conserved motifs are found in the ELO family three of which (Figure 1.6, 
motifs A, C, and D) have no similarity to motifs in other functionally characterized 
enzyme families.  The only conserved motif in ELOs that is familiar is a LHXXHH 
histidine box (motif B) that is found in enzymes that carry out oxidative reactions (e.g. 
fatty acid desaturases), where three or four histidine boxes are thought to bind iron (42).  
The unique characteristics of the ELO sequence suggests that these enzymes carry out the 
condensation reaction using novel chemistry, an understanding of which may impact the 
understanding and treatment of diseases.    
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Figure 1.6. Multiple sequence alignment of EloA from D. discoideum and related fungal 
ELOs.  The four motifs, A, B, C, and D, found in all members of the ELO family are 
boxed while residues absolutely (*) or highly conserved (#) in all known ELOs are 
indicated below the EloA sequence.  Gene accession #s: S. cerevisiae ScELO1, 
NP_012339; ScELO2, NP_009963; ScELO3, 013476; Hansenula polymorpa HaELO1, 
AB194620; Mortierella alpina, AAF71789; and D. discoideum, EloA, EU82617.  
 
 
 
For this study, an elongase (EloA) model system (17) from the cellular slime 
mold Dictyostelium discoideum (that shows a condensation reaction of 16:1Δ9 to 18:1Δ11) 
was used to examine the possible roles of highly conserved residues found in the four 
conserved motifs among the ELO family in the condensation reaction.  A likely low 
resolution model was generated from the consensus of transmembrane-spanning domain 
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prediction algorithms (Figure 1.7) (17) to elucidate the orientation of the highly 
conserved residues along the membrane-spanning domains of EloA.  The model predicts 
that the substrate enters through the cytosol and interacts with those residues present 
along the four conserved motifs.   
 
 
Figure 1.7. Topology model of four key membrane-spanning domains of EloA (17).  
Dark gray boxes indicate four ELO consensus motifs, within which most of the highly 
conserved residues in ELOs are found. 
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1.3 Dictyostelium discoideum 
Dictyostelium discoideum is a social amoeba that lives in the soil of temperate 
forests and is used as a model eukaryotic organism.  During the amoeboid life stages, D. 
discoideum, ingests bacteria and yeast; however, upon starvation, up to 100,000 cells 
aggregate and become a multicellular organism. As a result of this transformation, a 
fruiting body is produced which consists of a stalk that supports a spore head (43, 44) 
(Figure 1.8).  The life stage of D. discoideum takes a total of 24 h in a laboratory setting. 
 
 
Figure 1.8.  Composite electron micrograph of the developmental stages of D. 
discoideum upon starvation. © M.J. Grimson & R. L. Blanton.  The micrograph shows 
the life stages of D. discoideum.  D. discoideum  starts as mounds of cells that develop 
into either a finger-like structure or a migrating slug.  After some period of photoaxis, a 
“Mexican hat” like structure develops which ultimately gives rise to the fruiting body 
(45).  
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Phylogenetically, D. discoideum is found along the animal branch diverging before 
fungi; it is more closely related to animals than fungi (Figure 1.9) (43).  Important 
proteins such as those involved in G-protein signaling and cell cycle control (43) found in 
D. discoideum are very closely related to those found in animals thus supporting its closer 
relationship with animal cells than that observed between yeast and animals (46).  The 
similarity of Dictyostelium to animals has prompted is use in the study of human gene 
orthologues linked to human diseases, e.g., genes linked to cancer, neurological diseases 
and renal diseases among others (43).  
 
 
Figure 1.9.  Eukaryotic phylogenetic tree illustrating the position of D. discoideum (box).  
The tree was constructed using orthologous protein clusters from eukaryotic proteomes 
(43). 
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The unique life cycle of D. discoideum makes this organism an excellent candidate to 
conduct studies examining cell-cell interactions, intracellular/intercellular signaling, 
cellular differentiation and development, and fatty acid elongation (46). The fatty acid 
profile of D. discoideum shows a variety of fatty acids and VLCFAs with chain lengths 
ranging from C16 to C22 and various degrees of unsaturation (Table 1.1) (17).  
Interestingly, the majority of fatty acids found in D. discoideum vegetative cells are Δ11-
unsaturated C18 fatty acids, suggesting that these fatty acids could be the products of a 
16:1Δ9 elongation.  Further support for a fatty acid elongation pathway in D. discoideum 
is provided by the presence of 20:0 and 22:0 (17). 
 
Table 1.1.  Fatty acid profile of D. discoideum.  Table shows mean percent composition   
± sd of fatty acid pyrrolidides prepared from cellular total lipids (17). 
Fatty acid Mean % Composition Fatty acid Mean % Composition 
16:0 9.42 ±	  1.70 18:0 Trace 
16:1Δ5 0.97 ±	  0.14 18:1Δ9 2.88 ±	  0.31 
16:1Δ9 6.89 ±	  0.44 18:1Δ11 36.56 ±	  3.30 
16:2Δ5,9 5.14 ±	  0.31 18:2Δ5,11 32.27 ±	  1.33 
17:0 1.38 ±	  0.33 18:2Δ7,11 5.90 ±	  1.24 
17:1Δ9 Trace 20:0 Trace 
17:2Δ5,9 1.33  ±	  0.09 22:0 2.15 ±	  1.07 
 
D. discoideum  serves as an important model to study fatty acid elongation as it 
possess the two types of condensing enzymes, KCSs and ELOs (17) with four ELO genes 
and one 3-ketoacyl-CoA synthase gene found in this organism.  More importantly, 
research has shown that elongation of unsaturated and saturated fatty acid substrates 
occurs in D. discoideum (17).  Previously, a highly active ELO from D. discoideum was 
cloned and characterized in yeast this ELO (EloA) was shown to elongate 16:1Δ9 to 
18:1Δ11 (17).   
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1.4  Research Objectives 
ELOs play an important role in fatty acid elongation and determining their 
mechanism can lead to a better understanding of this type of enzymes.  Additionally, 
ELOs are known to play important roles in certain diseases and understanding their role 
may lead to better therapies. Little is known regarding ELOs and how they catalyze 
condensation reactions.  EloA, from D. discoideum, possesses characteristic traits found 
in the ELO family, which makes it a good candidate to conduct biochemical assays that 
would help us better understand the possible roles of the Histidine box and other motifs 
conserved in EloA. 
 
In the study outlined herein, site-directed mutagenesis and immunoblotting studies 
were used to determine if the highly conserved residues found in the ELO family and 
EloA have a role in ELO structure or function.  Table 1.2 shows the targeted amino acids 
during site-directed mutagenesis.  Furthermore, these studies included determining 
parameters for the solubilization and isolation of this condensing enzyme using 
hexahistidine fusion proteins as a purified protein is needed to perform specific 
experiments that will point out exactly what residues, if any, participate in the 
condensation mechanism. 
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Table 1.2.  Targeted highly and absolutely conserved amino acids in EloA and respective 
mutations. 
Target residue Mutation Target residue Mutation 
Tyrosine (Y45) Alanine Histidine (H148)  Alanine 
Tyrosine (Y45) Phenylalanine Asparagine (N173) Alanine 
Serine (S79) Alanine Histidine (H177) Alanine 
Cysteine (C104) Alanine Methionine (M180) Alanine 
Lysine (K123) Alanine Tyrosine (Y181) Alanine 
Glutamic acid (E126) Alanine Tyrosine (Y181) Phenylalanine 
Aspartic acid (D129) Alanine Threonine (T200) Alanine 
Threonine (T130) Alanine Glutamine (Q203) Alanine 
Histidine (H144) Alanine Glutamine (Q206) Alanine 
Histidine (H147) Alanine Phenylalanine (F252) Alanine 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Suppliers 
Bacto™ yeast extract, Bacto™ peptone and Fisher Scientific dextrose were used in media 
preparation.  Primers from IDT Integrated Technologies were developed for subcloning 
and site-directed mutagenesis experiments.  The Quick Change II site-directed 
mutagenesis kit from Stratagene was used to create mutants of EloA.  Common 
molecular biology analysis such as DNA isolation from E. coli cells was performed using 
Promega Wizard Plus Miniprep DNA kit and sequencing reactions for EloA and site-
directed mutants were prepared using Applied Biosystems Big Dye Terminator v3.1 
Cycle Sequencing kit.  Stratagene XL-1 Blue competent E. coli cells were used for E. coli 
transformations while Invitrogen InvSc1 S. cerevisiae competent cells were used for 
yeast transformations.  Thermo Scientific Triton™ X-100 was used during the 
solubilization of EloA and tagged fusion proteins. 
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2.2 Escherichia coli Transformation 
Stratagene and RbCl2 (47) XL-1 Blue competent E. coli cells were used for E. coli 
transformations depending on the experiment.  XL1-Blue Stratagene or RbCl2 competent 
cells (50-100 µl) were incubated with transforming DNA (~10 ng) on ice for 30 min.  The 
mixture was heat-shocked for 45 s in a 42 °C water bath followed by a 2 min incubation 
on ice. LB media (1 ml, Appendix A) or SOC broth for Stratagene competent cells (500 
µl, Appendix A) was added to the mixture and incubated at 37 °C for 1 h with shaking at 
250 rpm (New Brunswick, INNOVA 44 Incubator Shaker Series) shaking.  Stratagene 
cells (250 µl) were spread on LB + amp plates (Appendix A) and incubated at 37 °C for 
16 h.  For RbCl2 transformations, the LB mixture was inverted a couple times followed 
by an incubation at 37 °C for 1 h.  Cells were pelleted at 3,000xg for 30 sec, 900 µl of the 
supernatant was removed and the remainder was used to resuspend pelleted cells.  The 
cells were spread on LB + amp plates and incubated at 37 °C for 16 h.  
 
 
2.3 Saccharomyces cerevisiae Transformation 
S. cerevisiae competent cells (InvSc1, Invitrogen) were prepared by growing cells 
in 100 ml YPAD  (Appendix A) rich media at 30 °C with shaking at 250 rpm until an 
optical density at 600 nm (OD600) of 0.5-0.7 A was reached.  The grown cells were 
pelleted for 5 min at 1,900xg (IEC HN-SII Centrifuge, Damon) and resuspended in 0.1 M 
LiAc, 10 mM Tris, 1mM EDTA pH 8.0 to an OD600 of 0.6 A. Competent cells were 
stored on ice at 4 °C over night.  Transformations were carried out by the lithium acetate 
method (48) which required 100 µl of pelleted competent cells followed by layered 240 
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µl 50% PEG 3350, 36 µl 1 M LiAc, 25 µl 2 mg/ml salmon sperm DNA, sample DNA 
(100-200 ng/ µl) and water.  Cells were gently resuspended by pipetting and incubated at 
30 °C for 30 min followed by a 25 min incubation at 42 °C.  The mixture was centrifuged 
for 2 min at 3,000xg, the supernatant was removed and cells were resuspended with 250 
µl of water.  Transformants were selected for growth on complete minimal media plus 2% 
dextrose plates (cm-his/ura + 2% dextrose, Appendix A), depending on the transforming 
plasmid, for three days at 30 °C.  
 
 
2.4   Site-Directed Mutagenesis of Conserved Residues in EloA 
Highly conserved residues in the ELO family, determined by Clustal W2 (DNA 
Star) (17) multiple sequence alignment of ELOs from different organisms (Figure 1.6), 
were mutated using the Quik Change II Site-Directed Mutagenesis Kit (Stratagene, La 
Jolla, CA).  Forward and reverse primers (Integrated DNA Technologies, Coralville, IA) 
were designed to mutate the targeted residue to either alanine (GCT, GCC, GCA) or 
phenylalanine (TTT) (Table 2.1) and prepared at a stock concentration of 2000 ng/µl.  
The mutagenesis extension reactions were prepared as described by the manufacturer 
(Table 2.2) with EloA inserted into the vector pESc-His (Statagene) as the template.   
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Table 2.1. Site-directed mutagenesis forward (F) and reverse oligonucleotide primers 
(not shown, complementary to forward primers) were used to introduce alanine or 
phenylalanine mutations into the EloA gene using the QuikChange II Site-Directed 
Mutagenesis Kit.  Letters in bold indicate those nucleotides that were different from the 
wild-type sequence. 
 
 
Table 2.2. Site-directed mutagenesis reactions, as specified by manufacturer. 
Ingredient Amount 
10X Reaction buffer: 
100 mM KCl, 100 mM (NH4)2SO4, 200 mM Tris-HCl, 200 mM MgSO4, 
1% Triton X-100, 1 mg/ml BSA 
 
2.5 µl 
template 25 ng 
forward oligonucleotide primer 62.5 ng 
reverse oligonucleotide primer 62.5 ng 
dNTP mix 0.5 µl 
molecular biology H20 up to 25 µl 
Pfu Ultra High-Fidelity DNA polymerase (25 U/µl) 0.5 µl 
Mutation   Primer Sequence 
Y45A F: 5’-GTATGTTCATTTGGTGCTTTGGCATTAATTTAT 
Y45F F: 5’-GTATGTTCATTTGGTTTTTTGGCATTAATTTAT 
S79A F: 5’-AATTTATTCTTATGTTTATTAGCATTATTAATGTTTTTAGGTATT 
C104A F: 5’-CATGGTTTATACAATATAATTGCTAAACCAATTGATAGTGGTTTA 
K123A F: 5'-CAGTTATTACATTTTCTATCTTAGTGCAGTTTATGAATTTATTGATACAATAATTCAAG 
E126A F: 5’-TTCTATCTTAGTAAAGTTTATGCATTTATTGATACAATAATTCAA 
D129A F: 5’-CTTAGTAAAGTTTATGAATTTATTGCACAATAATTCAAGTTTTA 
T130A F: 5’-ATGAATTTATTGATGCAATAATTCAAGTTTTA 
H144A F: 5’-AAGTTTATTATTTTTAGCTGTATGGCATCAT 
H147A F: 5’-ATTTTTACATGTATGGGCTCATTTCATTACATT 
H148A F: 5’-TACATGTATGGCATGCTTTCATTACATTATG 
N173A F: 5’-GTCAATGGGTAGATATTTCAGCAGCTTGTTTCGTTCATATTGTTATGTAC 
H177A F: 5’-GATATTTCAGCAAATTGTTTCGTTGCTATTGTTATGTACTTTTATTATTTCCAAAC 
M180A F: 5’-CGTTCATATTGTTGCCTACTTTTATTATTTCC 
Y181A F: 5'-CAGCAAATTGTTTCGTTCATATTGTTATGGCCTTTTATTATTTCCAAACGTAACGTGG 
Y181F F: 5’-GTTTCGTTCATATTGTTATGTTCTTTTATTATTTCCAAACTGAAC 
T200A F: 5’-GGAAAAAACATATTGCAACTTGTCAAATCATACAATTCATAGTTG 
Q203A F: 5’-ATTACAACTTGTGCAATCATACAATTCATAGTTGATATGAGTTCAC 
Q206A F: 5’-CTTGTCAAATCATAGCATTCATAGTTGATATG 
F252A F: 5’-ATTTTATCATTCCTTGGTTTAGCCATTCAATTCTTTGTAAAAGCA 
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The mutagenesis primers were extended during temperature cycling (Eppendorf Gradient 
Cycler) as indicated in Table 2.3.  Following the generation of the mutated plasmid, the 
parental DNA was digested with 0.5 µl Dpn I restriction enzyme (10 U/µl) for 1 h at 
37 °C.  After Dpn I digestion of the parental template, the mutated plasmids were 
transformed into E. coli XL-1 Blue (Stratagene) cells and grown on LB + amp for 16 h at 
37 °C.  Transformants were picked and grown in LB + amp (5 ml LB with 0.1 mg/ml 
ampicillin) for 16 h with shaking (250 rpm) at 37 °C.  The plasmids were isolated and 
purified by Wizard Plus Miniprep DNA kit (Promega, Madison, WI) and sequenced with 
BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems Foster City, CA) 
using vector-directed primers (Gal 1) to confirm the installation of the desired mutation 
(Table 2.4, Table 2.5).   
 
Table 2.3. Site-directed mutagenesis temperature cycling parameters 
Step Temperature  Time 
1 95 °C 30 s 
2   95 °C  30 s 
3 55 °C   1 min   
4 68 °C 6 min 
Go to 2, repeat 24 times, hold at 4 °C 
 
Table 2.4. Cycle sequencing reactions 
Ingredient Amount 
template 300 ng 
primer (Forward/Reverse) 2 µM 
5x BigDye sequencing buffer 3 µl 
terminator ready reaction mix 2 µl 
molecular biology H2O up to 20 µl 
 
 
 
 
  
23 
23 
Table 2.5. BigDye Terminator cycle sequencing parameters 
Step Temperature Time 
1 96 °C 1 min 
2 96 °C 10 sec 
3 50 °C 5 sec 
4 60 °C 4 min 
Go to 2, repeat 24; hold at 4 °C 
 
Extension products were purified by ethanol/EDTA/sodium acetate precipitation with 3 
M sodium acetate/0.5 M sodium ethylenediaminetetraacedic acid, pH 8.0 (2 µL) and 80 
µL 95% ethanol and centrifuged for 15 min at 16,100xg (Eppendorf Centrifuge 5415R).  
The pellet was treated with 125 µl of cold 70% ethanol followed by centrifugation for 15 
min at 16,100xg centrifugation to remove salt residue and samples were allowed to air 
dry. 
 
The samples were sent to Miami University Center for Bioinformatics and 
Functional Genomics for sequencing and the resulting sequences and electropherograms 
were analyzed using Lasergene® SeqMan Pro (DNASTAR, Madison, WI) where the 
forward and reverse sequences were aligned with the wild-type sequence to confirm the 
presence of the desired mutation 
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2.5 Fatty Acid Methyl Ester Preparation and Analysis 
Single S. cerevisiae transformed colonies were grown in 5 ml YPAD rich media for 
16 h at 30˚C with shaking at 250 rpm.  Expression cultures (5 ml, cm-his + 2% galactose) 
were inoculated with 50 µl of starter culture and grown at 30˚C with shaking at 250 rpm 
for 3 days.  Equal cell numbers were collected by centrifugation for 5 min at 1,900xg and 
the supernatant removed.  Fatty acid methyl esters (FAMEs) were prepared by 
transesterification with 2% sulfuric acid in methanol (0.5 ml) and incubation at 80˚C for 
one hour. 
 
Prepared FAMEs were extracted from the transesterification reactions upon 
addition of 0.5 ml H2O with hexanes (2 x 1 ml) and dried under N2 gas.  Hexanes (200 µl) 
were added to redissolve the FAME sample which was analyzed by gas 
chromatography/mass spectrometry (GC/MS) with an Agilent Technologies 7890A 
GC/5975C MS and HP5 column (J & W Scientific) using the following oven conditions: 
100 °C for 3 min, ramp 30 °C/min to 200 °C, ramp 2.5 °in to 250 °C, ramp10 °C/min to 
290 °C and hold for 1 min, decrease 60 °C/min to 100  °C.  
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2.6 Microsome Preparation from Yeast Expressing EloA 
To make microsomes from EloA-expressing yeast, YPAD starter cultures (5 ml) 
were inoculated with a single transformant and grown for 16 h at 30°C with shaking (250 
rpm).  Expression cultures (40 ml, cm-his + 2% galactose) inoculated with 0.4 ml of 
starter culture were grown overnight at 30˚C with shaking (250 rpm) (14).  Cells were 
pelleted by centrifugation at 1,900xg for 5 min, resuspended in isolation buffer (IB; 80  
mM Hepes-KOH pH 7.2, 10 mM KCl, 320 mM sucrose, 5 mM EDTA pH 8.0, 5 mM 
EGTA pH 8.0, 0.1 M PMSF and 31 µg/mL benzamidine) and lysed by homogenization 
(three times for 1 min with 2 min ice incubations between each bead beating) with glass 
beads (0.5 mm beads) on a Bead Beater (BioSpec Products).   
 
Unlyzed cells and debris were removed by quick microcentrifugation (12 sec x2; 
max speed 13,000xg) and collecting only the supernatant.  Microsomes were collected 
from the lysate diluted to 40 ml with IB by ultracentrifugation for 1 h at 50,000xg at a 
temperature of 4°C and the pellets resuspended in IB (200 µl).  The protein concentration 
of each sample was determined by the Bradford method (49) (Sigma-Aldrich, St. Louis, 
MO) using BSA as a standard and adjusted to 2.5 µg/µl by addition of IB and glycerol to 
15% (v/v).  Samples were frozen on dry ice and stored at -80 °C.  
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2.7 EloA Expression Analysis by Immunoblot 
Polyclonal antibodies (Cocalico Biologicals Inc, Reamstown, PA) were raised 
against a synthesized peptide derived from the EloA amino terminus (residues 1-20) and 
used in immunoblot assays to determine protein expression levels.  Microsomal protein 
(20 µg) treated with Laemmli buffer (50) was denatured for 5 min at 95 °C and separated 
on a 12% SDS-PAGE gel (Appendix A) at 100 V through stacking gel and then 140 V 
through the resolving gel. The separated proteins were transferred to a methanol-rinsed, 
transfer buffer pre-incubated in transfer buffer (30 min, Appendix A) Immobilon-P 
(Millipore) polyvinylidene fluoride membrane in transfer buffer with an ice pack and 
stirred for 2 h at 100 V (BioRad Mini Trans-Blot Cell, Hercules, CA). 
 
After transfer, the membrane was blocked with TTBS (100 mM Tris, pH 7.5, 150 
mM NaCl, 0.1% Tween 20) over night at 4°C and then incubated with anti-EloA (1/500 
dilution in TTBS) mixed with anti-Erg27p (1/300 dilution in TTBS; gift from Martin 
Bard, IUPUI) for 2 h with gentle shaking at room temperature.  The levels of EloA and 
Erg27p were detected upon incubation with goat-anti rabbit IgG horseradish peroxidase 
conjugate (Biorad; 1/2500 dilution in TTBS) for 1.5 h with gently shaking at room 
temperature followed by chemiluminescent detection (Pierce SuperSignal West Pico) on 
a photodocumentation system (BioRad Quantity One® 1-D Analysis Software; 2 min 
exposure at 15 second increments). 
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2.8 Engineering of N- and C-Terminally His6-tagged EloA Expression Plasmids 
Two different fusion proteins, one tagged at the amino (His6-EloA) terminus 
(Figure 2.1) and another tagged at the carboxy (EloA-His6) terminus, were constructed 
for the characterization of EloA.  The His6-EloA plasmid was constructed from an 
available pYES2 vector (Invitrogen) designed for fusion of the hexahistidine tag at the 
amino terminus.  EloA was amplified using primers containing restriction sites EcoRI at 
the 3’ and BamHI at the 5’, convenient for subcloning into pYES2 tagged yeast 
expression vector.  The EloA-His6  plasmid was designed by creating primers (Table 2.6) 
that incorporated a hexahistidine tag at the carboxy terminus of EloA and included a 
BamHI site (5’) after the tag to allow in-frame subcloning into the pYES2 vector.  
 
 
Table 2.6.  Amplification primers used during subcloning of EloA into pYES2 
Primers Sequence 
Reverse EcoRI His6-EloA 5’-GGGGAATTCTTAATTTGTTTTCTTTTTAATTGAAG-3’ 
Forward BamHI His6-EloA 5’-GGG GGA TCC ATG GAA CAT ATT CAT GA-3’ 
Reverse EcoRI EloA-His6 5’- ATC TTC ATT AAA AAG AAA ACA AAT (CAT)6 TAA-3’ 
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Figure 2.1.  The His6-EloA plasmid map (6594 bp) illustrates EloA subcloned into the 
yeast expression vector pYES2.  The map shows the presence of the hexahistidine tag 
(blue block) and the Gal1 promoter (blue arrow).  
 
 
The gene amplification reactions contained 2 µl of 10x amplification buffer (100 
mM  Tris-HCl pH 8.3, 500 mM KCl and  20 mM MgCl2), 2 µl of each 2 mM dNTP stock, 
0.2 µl Vent polymerase, 2 µl of template, 2 µl of each respective primer (5 µM stock) and 
3.8 µl of water and were amplified as outlined in Table 7.  PCR products were purified 
using QIAquick PCR purification kit protocol by QIAgen (Valencia, CA). 
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Table 2.7.  EloA Polymerase Chain Reaction Amplification parameters 
Step Temperature Time 
1 94 °C 2 min 
2 94 °C 15 s 
3 65 °C 15 s; increment step temp by -1 °C 
R=3 °/s +0.0°/s 
G= 0.0 ° 
4 72 °C 1 min 
5 go to 2, repeat 15  
6 94 °C 15 s 
7 50 °C 15 s 
8 72 °C 1 min 
9 go to 6, repeat 20 
10 72 °C 2 min 
11 hold at 4 °C 
 
 
The purified PCR products were digested with BamHI and EcoRI (Table 2.8)  and 
incubated at 37 °C for 1 h.  Digested products were purified by QIAEX II Gel extraction 
kit protocol by QIAgen (Valencia, CA) and ligated into the vector with T4 DNA ligase 
(Life Technologies, Gibco-BRL).  The ligation reactions contained 4 µl 5x ligase buffer, 
2 µl 10 mM ATP, 1 µl ligase, 6:1 insert to vector (v/v), and molecular biology water up to 
20 µl.  Reactions were incubated overnight at room temperature.  The ligation reactions 
(10 µl) were transformed into RbCl2 competent E. coli as described previously.  Insert-
containing plasmids were isolated by Wizard Plus Miniprep DNA kit and sequenced to 
rule out mutations. 
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Table 2.8.  Set up for digestion reactions.  
Vector: His6pYES2 Insert: EloA 
Ingredient Amount Ingredient Amount 
vector DNA 3.8 µl (0.34 µg/ µl) insert DNA 20 µl (0.07 µg/ µl) 
10X NEB 3 Buffer  5 µl 10X NEB 3 Buffer  5 µl 
100X BSA 0.5 µl 100X BSA 0.5 µl 
Bam HI 1 µl Bam HI 1 µl 
EcoRI 1 µl EcoRI 1 µl 
Molecular Biology   H2O up to 20 µl Molecular Biology  H2O up to 20 µl 
 
 
The yeast expression vector encoding the carboxy terminally-tagged EloA was 
constructed in a similar matter as that described for the amino tagged EloA and using a 
developed primer containing the hexahistidine tag (Table 2.6).  Plasmids were 
transformed into competent S. cerevisiae (InvScI, Invitrogen) as previously described. 
 
 
2.9 Solubilization and Isolation of His6-EloA  
Microsomes prepared from yeast expressing His6-tagged EloA fusion protein and 
those transformed with vector pYES2 were solubilized by incubation on ice for 2 h in 
solubilization buffer (320 mM NaCl, Triton X-100, in IB; 2 µg protein/µl).  Different 
percentages of Triton X-100 (0.1, 0.05, and 0 % v/v) were used during the solubilization 
experiments.  Insoluble material was pelleted by centrifugation at 4°C for 1 h at 16,100xg.  
Supernatants were frozen on dry ice and stored at -80°C. 
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Supernatants were combined with binding buffer (25 mM sodium phosphate, pH 
8.0, 0.5% Triton X-100, 150 mM NaCl and 10% glycerol (v/v)) at a ratio 0.43:1 
(supernantant:binding buffer) and applied to a 300-µl column of Ni-NTA Agarose resin 
(QIAgen) or TALON Cobalt affinity resin (Clontech, Palo Alto, CA).  The Ni/Co column 
was washed with 1 ml binding buffer, 1 ml wash buffer (25 mM sodium phosphate, pH 
8.0, 0.5% Triton X-100, 500 mM NaCl, 10% glycerol, and 20 mM imidazole), and 1 ml 
binding buffer.  Protein elution from the column was performed with 300 µl elution 
buffer (25 mM sodium phosphate, pH 8.0, 0.5% Triton X-100, 500 mM NaCl, 10% 
glycerol, and 300 mM imidazole) and dithiothreitol was added to 2 mM to the eluted 
fraction.  Eluted protein samples were frozen on dry ice and stored at -80°C.  
 
 
2.10 Condensation Assay  
Condensation activity was assayed as described previously (15, 27).  Material eluted 
from Ni/Co column (5 µl) was incubated with condensation reaction mix (20 µl; 10 mM 
sodium phosphate, pH 7.2, 0.05% Triton X-100, 15 µM [2-14C] malonyl-CoA and 20 µM 
16:1-CoA, H2O) at 30°C for 1 h.  The reaction products were reduced to diols by 
incubation with 0.5 ml of reducing agent (0.132 M NaBH4, 0.143 M K2HPO4, 0.57 M 
KCL and 30% distilled tetrahydrofuran) at 37°C for 30 min followed by the addition of 
15 µl of 12 N HCl.  The products were extracted into pentane (2 x 0.8 mL), evaporated 
under a N2 stream and quantified by methylene chloride liquid scintillation (Fisher 
Scientific) analysis using a Beckman LS 6000 Liquid Scintillation Counter.  As a 
negative control, empty vector mock-isolated samples were assayed in a similar matter.
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CHAPTER 3. RESULTS 
3.1. Introduction 
Sequence alignment of functionally characterized ELOs identified a number of 
highly conserved residues and four ELO family consensus motifs (17).  The main 
objective of the research described here was to analyze the possible role(s) of these 
residues found within the ELO family.  Although we do not know how ELOs catalyze the 
condensation reaction due to their lack of homology to other characterized condensation 
enzymes, we hypothesized that highly conserved residues found in ELOs from different 
organisms have a pivotal catalytic and/or structural function for the enzyme.  A model 
elongase condensing enzyme (EloA) (17) from the cellular slime mold, D. discoideum, 
shows a substrate specificity for monounsaturated fatty acids catalyzing the condensation 
reaction for the elongation of 16:1Δ9 to 18:1Δ11 and was used to examine the possible 
roles of these residues in the condensation reaction.  In addition, preliminary work was 
carried out to establish experimental parameters for the isolation of the D. discoideum 
condensing enzyme, EloA, upon heterologous expression in yeast to aid in the future 
characterization of this membrane-bound protein.  
 
Site-directed mutagenesis was used to target absolutely and highly conserved 
residues found in the ELO family.  The targeted residues were replaced with alanine or, 
in the case of tyrosine residues, to alanine or phenylalanine. 
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For this study, twenty mutants were made and expressed in yeast; FAMEs prepared from 
total yeast lipids were analyzed by GC/MS to determine the level of EloA activity.  Semi-
quantitation of expressed mutant and wild-type EloA protein levels were performed to 
examine the importance of these condensing enzymes during fatty acid elongation.   
 
 
3.2. Activity of EloA Site-Directed Mutants FAMEs Analysis 
The activities of wild-type and mutant EloA enzymes were examined upon 
expression in S. cerevisiae through the preparation of FAMEs from total yeast lipids 
followed by GC/MS analysis.  The separation of yeast-derived FAMEs, produced in the 
absence (A) and presence of EloA (B) was demonstrated by total ion chromatographs  
(TIC; Figure 3.1).  Fatty acid methyl esters observed in the TICs included 16:1Δ9 (10.5 
min), 16:0 (10.7 min), 18:1Δ9 (13.3 min), 18:1Δ11 (13.4 min), 18:0 (13.8 min) and 20:1 
(17.9 min, B).  The yeast empty vector (EV, A) used for expression of EloA and site-
directed mutants has endogenous elongases that show background elongation activity 
thus providing a small percentage of the 18:1Δ11 elongation product.  In order to account 
for this background activity, empty vector samples were prepared and analyzed in the 
same manner as were the mutant samples.  Compared to yeast transformed with EV, 
yeast expressing EloA had a higher percentage of elongation product 18:1Δ11 and the 
production of a new fatty acid 20:1. 
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Figure 3.1. Total Ion Chromatogram (TIC) of FAMEs from yeast expressing empty vector (EV) 
pESc (A) and EloA (B).  
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FAME analysis showed that yeast transformed with empty vector or wild-type 
EloA had different fatty acids profiles (Table 3.1).  One of the major differences between 
the empty vector and wild-type EloA was the decrease in 16:1 Δ9 and a reciprocal increase 
in 18:1Δ11.  The yeast transformed with empty vector showed a mean of 39.4 ± 3.3% for 
16:1Δ9 versus a mean of 17.5 ± 1.4% seen in yeast expressing wild-type EloA.  However, 
the percentage of 18:1Δ11 observed in yeast that expressed empty vector was a mean of 
1.8 ± 0.3% versus a mean of 10.9 ± 0.5% seen in yeast expressing wild-type EloA.  The 
increase in the amount of the 18:1 Δ11 elongation product demonstrates the elongase 
activity of EloA.  
 
The fatty acid profile of yeast expressing each of the EloA site-directed mutants is 
presented in Table 3.1 and Figure 3.2.  Upon analysis of the percentage of the EloA 
elongation product, site-directed mutants were grouped into three groups based on their 
activity relative to the wild-type enzyme: those within 20% of wild-type activity (10.1-
11.5% 18:1Δ11) (Y45F, S79A, H144A, and Y181F); those with between 10 and 60% of 
wild-type activity (4.0-8.0% 18:1Δ11; Y45A, C104A, E126A, M180A, Y181A, T200A); 
and those with little or no activity (1.9-3.5% 18:1Δ11; K123A, D129A, T130A, H147A, 
H148A, N173A, H177A, Q203A, Q206A, and F252A) (Figure 3.2).  The mutants with 
little or no activity had similar percentages of the other fatty acids (16:0, 16:1Δ9, 18:0) as 
those observed in the empty vector (Table 3.1).  The mutants within 20% and those 
within 10 and 60% of wild-type activity showed relatively similar percentages of other 
fatty acids as those observed in EloA. 
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Table 3.1. Fatty acid profiles of S. cerevisiae expressing EloA and site-directed mutants.  The % 
fatty acid of total fatty acids, determined by FAMEs analysis produced from total yeast cells, are 
expressed as the mean ± sd, n = 5-6. 
% FA ± sd 16:0  16:1∆9  18:0  18:1∆9  18:1∆11  
EV 23.7 ± 1.1 39.4 ± 3.3   7.4 ± 1.4 27.7 ± 0.7   1.8 ± 0.3 
EloA 11.6 ± 0.2 17.5 ± 1.4 11.8 ± 1.3 48.2  ±1.2 10.9 ± 0.5 
Y45A 17.6 ± 1.6 27.9 ± 2.1 11.3 ± 1.8 37.1 ± 1.0   6.0 ± 0.4 
Y45F 13.7 ± 0.4 19.5 ± 1.2 16.0 ± 1.2 39.3 ± 0.9 11.5 ± 1.2 
S79A 13.6 ± 0.7 20.1 ± 2.8 15.3 ± 1.7 40.6 ± 1.9 10.4 ± 0.5 
C104A 17.4 ± 0.3 28.8 ± 0.6 13.5 ± 0.4 32.3 ± 0.5   8.0 ± 0.3 
K123A 21.3 ± 1.7 34.1 ± 8.2 10.1 ± 2.3 32.4 ± 5.2   2.2 ± 0.4 
E126A 17.0 ± 0.3 30.2 ± 1.4   9.7 ± 1.3 37.0 ± 0.8   6.2 ± 0.3 
D129A 20.5 ± 1.0 35.5 ± 6.2   9.1 ± 1.4 32.6 ± 4.3   2.2 ± 0.6 
T130A 20.7 ± 0.9 30.9 ± 2.9   9.2 ± 1.6 35.9 ± 5.4   3.4 ± 0.9 
H144A 12.2 ± 0.7 20.1 ± 2.6 12.0 ± 3.1 45.6 ± 0.8 10.2 ± 0.5 
H147A 23.3 ± 0.7 39.9 ± 2.8   8.7 ± 0.8 25.3 ± 2.1   2.3 ± 0.2 
H148A 20.6 ± 1.2 36.4 ± 3.0   8.3 ± 0.7 32.1 ± 1.4   2.6 ± 0.3 
N173A 22.3 ± 1.4 34.6 ± 4.8   9.4 ± 1.5 31.4 ± 4.0   2.2 ± 0.4 
H177A 22.9 ± 1.0 37.5 ± 2.9   7.6 ± 1.0 30.1 ± 1.2   1.9 ± 0.2 
M180A 15.9 ± 0.6 26.7 ± 1.8 11.2 ± 2.6 39.1 ± 1.2   7.1 ± 0.6 
Y181A 18.2 ± 1.2 30.7 ± 5.5 12.3 ± 2.9 34.6 ± 3.0   4.3 ± 0.9 
Y181F 12.8 ± 0.5 18.0 ± 2.8 11.8 ± 1.1 47.3 ± 1.3 10.1 ± 0.7 
T200A 19.6 ± 2.7 28.8 ± 2.6 12.0 ± 1.3 35.6 ± 1.9   4.0 ± 0.7 
Q203A 21.5 ± 1.2 35.5 ± 2.1   8.6 ± 0.9 31.7 ± 1.5   2.7 ± 0.4 
Q206A 21.5 ± 0.2 34.8 ± 0.5 10.8 ± 0.2 29.5 ± 0.2   3.5 ± 0.1 
F252A 21.5 ± 0.6 32.7 ± 0.8 12.1 ± 0.4 30.2 ± 1.1   3.4 ± 0.2 
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Figure 3.2.  Production of 18:1Δ11 by EloA site-directed mutants.  Fatty acid methyl esters 
prepared from total yeast cellular lipids were analyzed by GC/MS.  18:1Δ11 as a percent of total 
FAMEs is presented as the mean +/- sd; n=5 or 6.  Note that S. cerevisiae has a low level of 
endogenous activity producing close to 2% of the total FAMEs. 
 
The activity of mutants within 20% of wild-type activity demonstrated that mutations of 
the conserved residues (Y45F, S79A, H144A, and Y181F) did not disrupt the function of 
the enzyme and that it is still able to produce wild-type like percentages of 18:1Δ11.  In 
contrast, the mutants with little to no activity of wild-type (K123A, D129A, T130A, 
H147A, H148A, N173A, H177A, Q203A, Q206A, and F252A) suggested that the amino 
acid residue changes at these positions disrupt the production of the main EloA product, 
18:1Δ11.  
 
Based on the levels of activity of the EloA mutants, a number of the residues 
explored appear to be involved in maintaining the correct structure of the protein.  The 
tyrosine residues (Y45 and Y181) were mutated to both alanine and phenylalanine and 
the activity of the tyrosine to phenylalanine mutants for both residues was within 20% of 
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the wild-type activity.  In contrast, when the tyrosine residues were mutated to alanine, a 
drastic decrease in activity was observed (46% and 28% of wild-type activity, 
respectively).  The disturbance in activity levels for the alanine mutant strongly suggests 
the participation of the tyrosine residue as a structural factor. 
 
 
3.3.  EloA Expression Analysis by Immunoblot 
The analysis of FAMEs prepared from yeast expressing the wild-type and mutant 
EloA only reflects the activity of the enzyme in vivo; therefore, site-directed mutants 
were analyzed by immunoblot assay to determine EloA expression levels.  Microsomes 
prepared from yeast expressing wild-type EloA and each mutant allele as well as yeast 
transformed with the empty expression vector were simultaneously probed with anti-
EloA and anti-Erg27p sera.  Erg27p is a 3-keto-reductase microsomal protein that 
participates in the C-4 demethylation of ergosterol biosynthesis intermediates in yeast (51) 
and was used as a loading control for total microsomal protein (Figure 3.3).    
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Figure 3.3. Immunoblot analysis of microsomes prepared from yeast expressing wild-type and 
mutant EloAs.  Microsomal protein (20 µg) was analyzed by immunoblot with anti-EloA and 
anti-Erg27.  
 
As expected, lanes loaded with microsomes derived from yeast transformed with the 
empty vector (pESc, EV) showed only a band corresponding to the loading control 
Erg27p (molecular mass = 39.7 kDa), while the lanes loaded with microsomes prepared 
from yeast expressing wild-type EloA and each mutant had two bands: the loading 
control and EloA (molecular mass = 32.2 kDa).  The immunoblot assay results indicated 
that the absence of EloA activity in yeast expressing the K123A, D129A, H147A, H177A, 
Q203A, Q206A, and F252A mutants demonstrated at least an equivalent level of staining 
with anti-EloA and a comparable ratio between EloA and LC staining as the wild-type.  
 
 
 
  
40 
40 
 Furthermore, most of the mutants showed at least comparable staining with anti-
EloA as the wild-type.  This suggests that the decreases in activity exhibited by these site-
directed mutants is not a result of protein expression levels but the effects of the residue 
mutation on the activity of the enzyme.  This observation again highlights the importance 
of the highly conserved residues.  An exception is M180A, which has a higher level of 
EloA protein staining compared to the wild-type enzyme.  M180A is a member of the 
group of mutants with 10 and 60% wild-type activity and the staining seen for the LC is 
comparable to the EV suggesting that this mutant allele expressed more EloA.   
 
 
3.4.  Study of His6-tagged EloA Expression through Analysis of FAMEs and 
Immunoblot 
After in vivo analysis of the wild-type and site-directed mutants, the optimal 
conditions to solubilize and perform preliminary isolation experiments of EloA were 
determined.  Determining optimal conditions for the solubilization and isolation of EloA 
would aid in the future characterization of this membrane-bound ELO.  The first step was 
to tag wild-type EloA by adding a hexahistidine tag at the amino and carboxy termini, 
separately. The tagged protein was then utilized to determine preliminary parameters and 
conditions for the solubilization and subsequent isolation of EloA. 
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Expression plasmids for EloA hexahistidine-tagged at the amino (His6-EloA) and 
carboxy (EloA-His6) termini were constructed and the activities of the resulting fusion 
proteins were examined by GC/MS analysis of FAMEs prepared from total yeast lipids.  
As performed previously, the production of 18:1Δ11 as a percentage of the total FAMEs 
was reported (Figure 3.4).  The results showed that the His6-EloA enzyme had within 2% 
of the wild-type activity, while the EloA-His6 enzyme was 19.5% less active than wild-
type EloA.    
 
 
Figure 3.4.  Production of 18:1Δ11 by pYES2, EloA, His6-EloA, and EloA- His6 upon expression 
in S. cerevisiae.  18:1Δ11 composition is represented as mean percent of total FAMEs ± sd (n=5 or 
4).  Wild-type and tagged protein were expressed from pYES2 (Invitrogen). 
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These results demonstrate differences in activity between the tagged and wild-
type EloA that may be attributed to the impact of the hexahistidine tag on the stability of 
the structure of the protein.  Once again these results were from in vivo experiments, and 
not assays of purified enzymes; therefore, yeast microsomes expressing the tagged 
proteins were prepared and protein expression levels analyzed by immunoblotting.  
Immunobloting analysis showed that protein staining in microsomes prepared from yeast 
transformed with the His6-EloA-containing plasmid was significantly less than that seen 
with the wild-type gene (Figure 3.5).  However, no staining with the anti-EloA sera was 
observed for the EloA-His6 protein (Figure 3.6), potentially due to low expression levels 
or the placement of the tag interfering with the antibody.  
 
 
 
Figure 3.5.  Immunoblot analysis of microsomes from yeast cells expressing tagged EloA. 
Microsomal protein (20 µg) was analyzed by immunoblot with anti-EloA.  The immunoblot 
shows empty vector pYES2 (A), His6-EloA subcloned into pYES2 B), EloA subcloned into pESc 
(C), and empty vector pESc (D) .  Wild-type EloA is 32.2 kDa and His6-EloA 33.1 kDa                                
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Figure 3.6 shows an attempt to determine the expression levels of both the tagged 
fusion proteins along with the wild-type subcloned into the pYES2 expression vector to 
allow for comparisons of staining between the wild-type and the tagged fusion protein.  
Unfortunately, in this experiment no staining with the anti-EloA sera was observed for 
the EloA-His6 protein or for the wild-type.  Based on these results, it was determined that 
the best option for the isolation/solubilization assays would be the His6-EloA as it 
showed wild-type like activity and immunoblot experiments showed staining for the 
tagged protein (Figure 3.5).   
 
 
Figure 3.6.  Immunoblot analysis of microsomes from yeast cells expressing tagged EloA. 
Microsomal protein (20 µg) was analyzed by immunoblot with anti-EloA.  Immunoblot shows  
EloA-His6 in pYES2 (A), His6-EloA in pYES2 (B), EloA in pYES2 (C), EloA in pESc (D), and 
empty vector pYES2 (E). 
 
 
The next step was to explore the optimal conditions for the solubilization and 
isolation of the membrane-bound EloA.  Optimization of solubilization conditions was 
conducted using yeast microsomes expressing EloA or empty vector, pESc.  The non-
tagged protein was used to determine solubilization conditions before moving to the 
solubilization of the tagged protein because of the difficulty in immunoblot detection of 
the tagged fusion proteins.  
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Yeast microsomes expressing EloA or empty vector were prepared as previously 
described and treated with different concentrations of Triton X-100 to determine the 
optimal detergent concentration for EloA solubilization (Figure 3.7).  The range of Triton 
X-100 concentrations tested were from 10-fold above to below the critical micelle 
concentration (CMC) of Triton X-100 of ~0.02% (w/v) (52).  
 
Figure 3.7.  Optimization of solubilization conditions for EloA.  Microsomes from yeast 
expressing EloA or pESc were prepared as described previously.  Microsomes were treated with 
320 mM NaCl and various percentages of Triton X-100 (0-2% (v/v)) followed by incubation on 
ice for 2 h and centrifugation to pellet insoluble material. Wild-type (EloA) and empty vector 
(pESc) (30 µl supernatant, S, or 30 µl pellet resuspension, P) were analyzed by immunoblot 
probed with anti-EloA and anti-Erg 27 and the chemiluminescent signal collected for 2 min.  First 
lane from right to left shows untreated microsomes samples prepared as stated.  
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Immunoblotting of the soluble (supernatant) and insoluble (pellet) fractions 
showed that at the higher concentration of Triton X-100 (2%, Figure 3.7), most of EloA 
was found in the supernatant but this could suggest that the sample is saturated with the 
detergent.  Additionally, 2% Triton X-100 is efficient but ten times more the CMC of 
Triton X-100.  Furthermore, when Triton X-100 was excluded from the reaction, most of 
the protein in both the wild-type and empty vector samples, remained in the pellet 
suggesting that no solubilization of Erg27p or EloA had occurred.  The concentrations of 
Triton X-100 tested were between 2 and 0.25% (v/v) and showed equivalent protein 
levels in both the pellet and the supernatant, disqualifying them as potential candidates 
for solubilization.  At 0.05%, equivalent protein levels in both pellet and supernatant 
were observed.   
 
The results showed that the optimal detergent concentration for solubilization of 
EloA was 0.1% Triton X-100 (Figure 3.7). At this Triton X-100 concentration, the pellet 
sample of the EloA microsomes showed little EloA staining while the supernatant sample 
showed substantial EloA staining suggesting that most of the protein remained in the 
supernatant of the sample.  The conditions determined in this experiment were used to 
solubilize microsomes expressing the tagged protein and pYES2 empty vector.  
 
 In an attempt to isolate solubilized His6-EloA, supernatants from the solubilization 
reactions were applied to both a nickel and a cobalt column.  The empty vector sample 
was also subjected to metal-affinity chromatography to determine if endogenous proteins 
were isolated with the column used; this served as a negative control for the isolation 
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experiment. The activity of microsomes, solubilized microsomes, and eluates from Ni2 
and Co2+ affinity chromatography of supernatants from His6-EloA and mock (EV) 
solubilization samples were monitored by a condensation assay, where the protein 
samples were incubated with an excess of radiolabeled substrate [2-14C] malonyl-CoA, 
and 16:1-CoA in a sodium phosphate buffer with 0.1% Triton X-100.  The 3-ketoacyl-
CoA condensation products were reduced to the diols, extracted, and subjected to liquid 
scintillation counting to monitor the reaction.   
 
Results (Figure 3.8) showed a decrease in radiolabeled material in the extracted 
products of the eluates compared to the microsomes suggesting that the activity of EloA 
was greatest in the microsomes when compared to the eluates.  A possible reason for this 
outcome is that the condensation assay measured the substrate not the product extraction 
allowing for the observed decrease in counts.  Another reason for the decrease in counts 
may be that the extraction of the diols was not efficient. Additionally, the condensation 
assay was conducted with equivalent sample volumes, not equivalent protein 
concentrations and it is  thus possible that the amount of protein in the assayed samples 
could have varied.  The observed results are likely due to a combination of nonequivalent 
protein concentrations and the extraction measuring the extracted diols and not the 
elongation product.    
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Figure 3.8.   Condensation assay monitoring enzyme activity.  Samples from empty 
vector (pYES2) and His6-EloA were isolated with a nickel or a cobalt column.  Samples 
(5 µl) were mixed with 15 mM [2-14C] malonyl-CoA, 10 mM sodium phosphate, pH 7.2, 
0.05% Triton X-100, 20 µM 16:1-CoA.
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CHAPTER 4.  DISCUSSION 
 
4.1   Site-directed Mutagenesis of Highly Conserved Residues in EloA 
ELOs are found in many organisms, including mammals, plants, protists, and 
fungi and have been shown to catalyze the condensation reaction of fatty acid elongation 
leading to the production of crucial fatty acids for many organisms.  The unique 
characteristics of this enzyme, such as not having a conserved catalytic triad, suggest that 
these enzymes carry out the condensation reaction using novel chemistry.  An 
understanding of the mechanism of these enzymes may impact the understanding and 
treatment of diseases such as Stargardt disease (8).  Although the mechanism by which 
ELOs catalyze the condensation reaction during fatty acid elongation has not been 
elucidated, we reasoned that the highly conserved amino acid residues targeted in this 
study are likely to have a structural and/or a catalytic role in ELO function.  Interest in 
the possible roles of these highly conserved residues led to the preparation of twenty 
individual EloA site-directed mutants.   
 
Analysis of EloA mutants revealed significant roles for some residues in the 
structure or the catalytic function of EloA.  In order to study the possible roles of the 
targeted residues, mutants were analyzed by quantifying the amount of EloA elongation 
product, 18:1Δ11%, from total FAMEs prepared from yeast expressing mutant EloA, EV, 
or wild-type followed by immunoblotting of microsomes prepared from yeast expressing 
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mutant alleles to determine levels of EloA expression.  Three categories of mutants were 
observed; those within 20% of wild-type activity; those with between 10 and 60% of 
wild-type activity; and those with little or no activity.  Immunoblotting results showed 
that most mutants have comparable EloA protein expression levels when compared to the 
wild-type suggesting that changes in activity were due to mutation disruptions and not 
low protein expression levels. 
 
Analysis of highly conserved aromatic residues by site-directed mutagenesis 
demonstrated a structural role rather than a catalytic role.  Tyr45 and Tyr181, highly 
conserved residues in the ELO family, were replaced with both alanine and phenylalanine 
residues.  The alanine mutations were installed to examine whether the aromatic ring 
found at these two positions is necessary for a stable, active enzyme while phenylalanine 
mutations tested the necessity of the hydroxyl group for the native structure and/or 
activity of the enzyme. In both cases, the alanine mutants (Y45A and Y181A) were 
considerable less active than the wild-type enzyme while the phenylalanine mutants 
showed near wild-type activity, suggesting that there is a structural requirement for the 
aromatic ring while the phenolic group is not necessary to maintain an active enzyme.  
These results are consistent with the observation that a number of the ELOs have a 
phenylalanine or tryptophan residue at the position equivalent to Y45 in EloA and 
suggest that these residues may play a similar structural role as the tyrosine  of EloA (12). 
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Claisen-like condensing enzymes have a catalytic triad (CHH/N) that is essential 
for catalysis.  The cysteine residue found in the catalytic triad is thought to covalently 
bind the acyl primer prior to condensation with the malonyl-CoA-derived C2 unit (11, 26).  
The sequence alignment of the functionally characterized ELOs (Figure 1.6) showed that 
the ELO family does not have an absolutely conserved cysteine residue; C104 of EloA is 
the only cysteine that is somewhat conserved (30% of sequences) in the family.  When 
assayed, the C104A mutation resulted in an active enzyme retaining 68% of the wild-type 
activity and indicating that this residue is not essential for condensation activity.  
Additionally, the model for EloA membrane topology (Figure 1.7) (17) places C104 in a 
loop found on the luminal side of the ER membrane, away from the cytosol where the 
acyl-CoA and malonyl-CoA substrates of the enzyme are found.  Thus, ELOs do not 
appear to covalently bind the acyl primer through a cysteine moiety, as there is no other 
conserved cysteine in the family.  
 
If the substrate acyl group is covalently bound in the EloA active site, it may be 
through an ester linkage with a serine, threonine, or tyrosine residue.  Two threonine 
residues (T130 and T200), modeled to be near the cytosol, were found to be important for 
activity (mutation to alanine resulted in 31% and 36% of wild-type activity, respectively).  
However, the stability of an ester linkage relative to a thiol ester linkage may make the 
subsequent condensation reaction less likely if the acyl group were bound through a 
hydroxyl side chain (53).  Alternatively, the acyl primer may not be covalently bound at 
all, implying that the active site binds two CoA-bound substrates at the same time. 
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The histidine box (LHXXHH; residues 143-148 in EloA) found in the ELO family 
is the only primary structural motif found in ELOs with an easily identifiable similarity to 
motifs found in other enzymes.  This motif is found in enzymes that catalyze oxidative 
reactions such as the fatty acid desaturases where it is essential and thought to bind the 
catalytic di-iron center (42).  A variation of the histidine box, where the first histidine is 
replaced with a glutamine (LQXXHH) is found in “front-end” fatty acid desaturases, 
such as the Δ6 desaturase from borage (54) that installs double bonds in fatty acids 
between the carbonyl group and an existing point of unsaturation at the Δ9  position, and 
in ELO homologs from Mortierella alpina (MALCE1p) and microalgae (Isochrysis 
galbana; IgASE1) (55, 56).   
 
The possible role of the conserved residues in the histidine box of EloA was probed: 
the mutation of H147 and H148 to alanine each abrogated EloA-catalyzed elongation 
activity (Figure 3.2) but had little effect on the protein level (Figure 3.3) while the 
H144A mutation maintained nearly 100% of the wild-type activity.  An imidazole group 
at position 144 is, therefore, not necessary for EloA activity but H147 and H148 are each 
important for EloA activity suggesting a possible role in catalysis and/or structure.  These 
results are consistent with those reported by Denic and Weismann who showed that a 
mutation of the second histidine in the histidine box of S. cerevisiae Elo2p (that 
corresponding to H147 of EloA) to alanine resulted in an inactive enzyme (41).  
Mutagenesis of the variant histidine box found in the I. galbana IgASE1 ELO (55) where 
the glutamine residue replacing the first histidine of the canonical histidine box was 
changed to either a histidine or an alanine, decreased activity but did not inactivate the 
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enzyme (57) while similar changes in the borage front-end desaturases abrogated activity 
(54, 58). Together these results indicate that the histidine box in the ELO family plays a 
different role than that in the desaturases and that there is a possibility that metal ions are 
not involved in the mechanism of the enzyme. 
 
The mutation of many residues that are predicted to reside at the cytosolic side of 
the ER membrane (Figure 1.7) (17, 41) from polar residues (K123, D129, N173, H177, 
Q203, Q206) to alanine, resulted in the inactivation of EloA (Figure 3.2).  As the acyl-
CoA and malonyl CoA substrates of the enzyme are found in the cytosol, these results 
suggest a possible role of these residues in either substrate binding or in catalysis.  The 
coenzyme A carrier of the acyl and malonyl groups is negatively charged suggesting that 
the positively charged residues (K123 and potentially H147, H148, H177) form salt 
bridges with the substrates. 
 
Interestingly, residues with apparent roles in discriminating among acyl substrates 
of different lengths are found at the lumen proximal end of ELO transmembrane domains 
and have been suggested to limit the length of the acyl chain accepted by a particular 
ELO (41, 59).  These studies, together with the findings of this study, strongly suggest 
that the acyl substrate enters a binding pocket within the membrane-spanning fold of the 
ELO with the methyl end leading and spanning the membrane while the carboxyl end is 
held at the cytosolic face where it is available for the condensation reaction with malonyl-
CoA.   
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Site-directed mutagenesis of highly conserved residues in D. discoideum EloA has 
provided insight into residues possibly involved in catalyzing the condensation reaction 
(Table 4.1) in ELOs.  It appears that the mechanism proceeds by a different pathway than 
that seen in fatty acid synthases, the related 3-ketoacyl-CoA synthases found in plants, 
and the polyketide synthases.    
 
Table 4.1.  Targeted highly and absolutely conserved amino acids in EloA, respective 
mutations and conclusions. 
Target residue Mutation Conclusion  
Tyrosine (Y45) Alanine phenyl group needed for active 
enzyme 
Tyrosine (Y45) Phenylalanine maintained near wild-type activity; 
OH not needed for active enzyme 
Serine (S79) Alanine within 20% wild-type activity 
Cysteine (C104) Alanine 68% wild-type activity, not part of 
catalytic triad 
Lysine (K123) Alanine little to no activity, could be forming 
ionic bonds or salt bridges with 
primer 
Glutamic acid (E126) Alanine between 10-60% wild-type activity 
Aspartic acid (D129) Alanine little to no activity 
Threonine (T130) Alanine little to no activity 
Histidine (H144) Alanine near wild-type activity 
Histidine (H147) Alanine little to no activity 
Histidine (H148)  Alanine little to no activity 
Asparagine (N173) Alanine little to no activity 
Histidine (H177) Alanine little to no activity 
Methionine (M180) Alanine between 10-60% wild-type activity 
Tyrosine (Y181) Alanine phenyl group needed for active 
enzyme 
Tyrosine (Y181) Phenylalanine maintained near wild-type activity; 
OH not needed for active enzyme 
Threonine (T200) Alanine between 10-60% wild-type activity 
Glutamine (Q203) Alanine little to no activity 
Glutamine (Q206) Alanine little to no activity 
Phenylalanine (F252) Alanine little to no activity 
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4.2   Preliminary Work Towards the Isolation of EloA 
In order to explore in more depth the mechanism by which ELOs catalyze the 
condensation reaction, it is essential to obtain purified enzyme.  Attempts to isolate EloA 
were conducted and began with the construction of expression plasmids for EloA 
separately hexahistidine-tagged at its amino (His6-EloA) and carboxyl (EloA-His6) 
termini.  The activity of the tagged protein was analyzed by preparing FAMEs from total 
yeast lipids and analyzed by GC/MS as previously performed by Blacklock et al. when 
isolating KCSs (15).  The production of 18:1Δ11 as a percentage of the total FAMEs was 
determined (Figure 3.4) and demonstrated that the His6-EloA was within 2% wild-type 
activity while the EloA-His6 plasmid was somewhat less active (19.5%) than wild-type 
EloA.  Based on these results, it was determined that the His6-EloA protein was the best 
candidate for our solubilization and isolation experiments.  In order to purify the enzyme, 
microsomes prepared from yeast expressing the tagged protein were solubilized and 
subjected to metal affinity chromatography to isolate the tagged protein.  
 
Here, we showed that the optimal detergent concentration for solubilization of 
EloA was 0.1% Triton X-100, which is ten times higher than the CMC of the detergent.  
The optimal concentration of Triton X-100 was determined by selecting a range of 
detergent concentrations above and below the CMC.  The optimal percentage of Triton 
X-100 determined in our experiment was comparable to percentages of Triton X-100 
used in isolation experiments reported previously (60).   
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Metal-affinity isolation of His6-EloA was attempted using two different columns: Ni-
NTA and Talon-Co affinity resin.  Preliminary results (Figure 3.8) were uncertain, as we 
are not aware of the state (properly folded or disrupted by the isolation experiment) of the 
eluted protein.   
 
Possible reasons for the observed results include the metal-affinity chromatography 
used; the experiment tested two columns but the results obtained were similar between 
the Ni and Co columns.    Additionally, as previously mentioned, the condensation assay 
measures the extracted formed diols not the elongation product making it difficult to 
quantify the activity of the enzyme.  Finally, there is a possibility that the enzyme was 
isolated by metal-affinity chromatography but it was inactive by the time it was assayed.  
Solutions for these problems include immunoblotting fractions collected from the column 
to determine at what point during the isolation the eluate contains the most protein and 
test by fraction with the most eluted protein by the condensation assay.   
 
Due to the membrane-bound nature of the protein of interest, other avenues must be 
pursued to determine optimal isolation conditions.  Small-sized tags in addition to the 
hexahistidine tag are available for protein purification, such as the polyarginine tag, 
FLAG tag (DYKDDDDK), c-myc tag (EQKLISEEDL), Strep II tag (WSHPQFEK) and 
S tag (KETAAAKFERQHMDS).  Another way to purify proteins includes the use of 
large peptides (26-396 residues); however, with an increasing size of the tag there is a 
larger risk of the tag interfering with protein-protein interactions (61).  The solubility can 
increase while tagged but the tag must be removed for certain experiments such as the 
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production of an antibody and crystallization of the protein (60, 61).  Additionally, many 
parameters, including effects on tertiary structure, pH, yield, purity, and cost (62) must be 
considered when choosing an affinity tag.   
 
A previously published study using a strep II tag placed at the amino or carboxy 
termini of a membrane-bound cytochrome P450 demonstrated an alternative method to 
successfully isolate a protein of interest (60).  The strep II tag-containing plasmid was 
expressed in S. cerevisiae and microsomes were isolated.  The microsomes were 
solubilized with a similar protocol and using the same percentage of Triton X-100 (0.1%) 
as those described in this study.  The use of the strep II tag at either the amino or carboxy 
termini resulted in the successful isolation with a Strep-Tactin® column of the membrane-
bound protein in its active form (60).   
 
Similarly, other studies show the successful isolation of an active ELOs using a 
FLAG tag (41).  The ELOs analyzed by Denic and Weissman were tagged at the C-
terminus and expressed in yeast.  Proteins were solubilized using either 1% Triton X-100 
or 2% digitonin and isolated by immunoprecipitation using an anti-FLAG resin.  The 
purified protein was reconstituted into proteoliposomes by detergent removal using SM2 
Bio-Beads in the presence of synthetic phospholipids.  Proteoliposomes were used for 
immonoblotting exeperiments.  A radiolabeled experiment using reverse-phase TLC was 
utilized to monitor the elongation activity of the enzyme by analyzing the reaction 
products (41).   
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Future experiments could include attempting to isolate EloA using the methodology 
reported by Denic and Weissman, which was similar to the methods utilized here but 
differed in the amount of detergent (1% used by Denic and Weissman vs. 0.1% used in 
this study), the method of isolating, and the purified protein activity assay. 
 
Although previous studies have reported the successful isolation of active 
membrane-bound proteins, the isolation of active EloA was not achieved in this study.  
Future studies of the purification of membrane-bound EloA require the testing of 
different affinity tags, a higher detergent concentration, and improvements on the assays 
conducted to assay the activity of the isolated enzyme.  For example, EloA could be 
tagged with FLAG and immunoprecipitation could be used to isolate protein from 
microsomes prepared from yeast expressing EloA followed by reconstitution of purified 
protein into proteoliposomes.  Once the active form of EloA has been isolated, the 
mutants created can be assayed to determine if the residues have a role in the individual 
steps of the condensation reaction and determine what these steps might be in the 
condensation mechanism of ELOs.   
 
Further, the isolation of active EloA could allow the crystallization of the protein 
and a better model.  Furthermore, the highly conserved residues could be mutated to 
residues with similar characteristics.  Mutating residues to similar amino acids could 
provide insights into their role in the condensation mechanism.   
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For example, mutating K123 to an arginine residue maintaining the positive charge or 
changing it to a negatively charged residue to test the effects if the side chain participates 
in the anchoring the substrate. 
 
Knowing how ELOs behave mechanistically can benefit research on human 
diseases, as previously mentioned mutations of ELOs are known to lead human disease.  
Another example is Trypanosoma brucei‘s Elop homologs instructing the synthesis of 
short fatty acids that are important during the parasite’s invasion of a host’s immune 
system (63),  other ELOs could have similar roles.  Understanding how ELOs behave can 
lead to drug development or therapeutic design for diseases such as 
adrenoleukodystrophy (ALD) which is a neurodegenerative disease due to demyelination 
of the nervous system caused by overproduction of C26 saturated fatty acids (64).  
Overall, the findings reported here led to a better understanding of the mechanistic 
behavior of ELOs through the analysis of site-directed EloA mutants.  Our findings 
should serve as a stepping-stone for the isolation of EloA.   
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APPENDIX 
Luria Broth (LB) plus ampicillin media/plates  
Prepared the following in 500 ml nanopure H2O and autoclaved at 15 psi for 20 min: 
o 5g Tryptone 
o 2.5g  Bacto Yeast Extract 
o 5g NaCl 
o 7.5g Agar* 
o 1 NaOH pellet* 
*Ingredients added for LB + amp plates 
Ampicillin (0.5 ml) was added after autoclave cool down.   
 
SOC Broth 
Prepared the following in 500 ml nanopure H2O and autoclaved at 15 psi for 20 min: 
o 10g Tryptone 
o 2.5g Bacto Yeast Extract 
o 10 mM NaCl 
o 2.5 mM KCl 
o 10 mM MgCl2 
o 10 mM MgSO4 
 
Complete minimal media-histidine/uracil plus dextrose plates: 450 mL volume.   
Prepared the following in 450 mL nanopure H2O and autoclaved at 15 psi for 20 min: 
o 0.65g Dropout powder premix*  
o 0.85g Yeast nitrogenous base w/o amino acids and ammonium sulfate 
o 2.5g Ammonium sulfate 
o 10g Dextrose 
o 10g Agar 
o 1 NaOH pellet  
 
* Recipe obtained from Current Protocols in Molecular Biology Volume 2, 13.1 
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Complete minimal media-histidine/uracil: 450 mL volume. 
Prepared the following in 450 mL nanopure H2O and autoclaved at 15 psi for 20 min: 
o 0.65g Dropout powder premix 
o 0.85g Yeast nitrogenous base w/o amino acids and ammonium sulfate 
o 2.5g Ammonium sulfate 
 
YPAD media: 500 mL volume.   
Prepared the following in 500 mL nanopure H2O and autoclaved at 15 psi for 20 min: 
o 5g Bacto yeast extract 
o 10g Dextrose 
o 10g Peptone 
o 15mg Adenine Hemisulfate 
 
12% Sodium Dodecyl Sulfate (SDS) polyacrylamide gels 
o 2.4 mL 30% Acrylamide (29:1) 
o 2.0 mL Sterile H2O 
o 30 µL 20% SDS 
o 1.5 µL 1.5 M Tris pH 8.8  
o 50 µL 10 % Ammonium persulfate (APS, made fresh) 
o 5 µL Tretramethylethylenediamine (TEMED) 
 
Added a layer of 0.01% SDS liquid and allowed to polymerized over night at 4 °C 
 
Removed 0.01% SDS liquid layer and prepared stacking gel as follows: 
o 0.25 mL 30% Acrylamide (29:1) 
o 1.12 mL Sterile H2O 
o 9.5 µL 20% SDS 
o 0.47 mL 0.5 M Tris pH 6.8 
o 2.5 µL 10% APS (made fresh) 
o 2.5 µL TEMED 
 
5X SDS Electrophoresis Buffer* 
o 125 mM Tris-Cl, pH 8.3 
o 960 mM Glycine 
o 0.5% SDS 
o H2O to 1L 
* Current Protocols in Molecular Biology Volume 2, 10. 
 
Western Transfer Buffer 
o 3 g Tris Base 
o 14.4 g Glycine 
o 200 ml Methanol 
o H2O to 1L  
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